Research spots rare type immune cells for response against Cancer: Study

Q: How long will it take to read this news story?

The story "Research spots rare type immune cells for response against Cancer: Study" has 481 words across 14 sentences, which will take approximately 3 - 5 minutes for the average person to read.

Q: Which news outlet covered this story?

The story "Research spots rare type immune cells for response against Cancer: Study" was covered 5 hours ago by Business Standard, a news publisher based in India.

Q: How trustworthy is 'Business Standard' news outlet?

Business Standard is a fully independent (privately-owned) news outlet established in 1975 that covers mostly business and finance news. The outlet is headquartered in India and publishes an average of 189 news stories per day. It's most recent story was published 2 hours ago.

Q: What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

Q: How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.<ul><li>News ID: #25757280</li><li>URL: https://chronographically.beamstart.com/news/research-spots-rare-type-immune-17385485741213</li></ul>

Business Standard Logo Business Standard 5h ago

Research spots rare type immune cells for response against Cancer: Study - Business Standard

Quick Summary:

Stock Market LIVEStocks to Watch TodayUnion Budget 2025 LIVEWhat is Standard Deduction?

The University of Melbourne's Dr Daniel Utzschneider, Laboratory Head at the Doherty Institute, said the findings could lead to advancements in immunotherapy treatments and the development of vaccines that provide long-lasting protection.

The research also found that certain signals in the body could increase the number of ID3+ T cells, paving the way for improved treatments like CAR T cell therapy.